Novo Nordisk A/S Sponsored ADR Logo

Novo Nordisk A/S Sponsored ADR (NVON)

BMV

Currency in MXN
689.99
+18.08 (+2.69%)

Real-time Data

02:30 PM

Day's Range

681.00
695.00

52 wk Range

637.43
1,119.03

Overview - NVON - Novo Nordisk A/S Sponsored ADR

Key Statistics

Valuation

Enterprise Value

8.42T

P/E (Trailing)

‪9.84‬

PEG Ratio

‪-0.48‬

Price / Sales (TTM)

‪9.18‬

Price / Book

‪5.20‬

EV / EBITDA

‪18.00‬

Profitability

Gross Margin

‪78.21%‬

Profit Margin

‪35.34%‬

Operating Margin

‪42.54%‬

Return on Assets

‪18.72%‬

Return on Equity

‪59.81%‬

Ownership

Shares Outstanding

4.42B

Float

3.17B

Held by Insiders

‪0.0030%‬

Held by Institutions

‪9.90%‬

Price stats

Beta

‪0.34‬

50-Day Avg

‪788.50‬

200-Day Avg

‪801.74‬

Dividends

Payout Ratio

‪44.46%‬

Frequency

Semi-Annual

News Teaser - NVON - Novo Nordisk A/S Sponsored ADR

News & Analysis

View all news

Market Cap - NVON - Novo Nordisk A/S Sponsored ADR

Peers - NVON - Novo Nordisk A/S Sponsored ADR

Peer Comparison

Compared with companies in Drug Manufacturers - General listed on BMV.

Profile Summary - NVON - Novo Nordisk A/S Sponsored ADR

About

Novo Nordisk A/S Sponsored ADR is a healthcare company focused on discovering, developing, manufacturing, and marketing pharmaceutical products. The company’s current business is organized around diabetes and obesity care, where it offers treatments and related devices for chronic metabolic conditions, and rare…

SectorHealthcare
IndustryDrug Manufacturers - General
Employees67.90K
Full company profile

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Charting by TradingView.

Last updated:

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.